Document is current
Any future updates will be listed below
-
Authors
Karakaslar, E. Onur
Severens, Jeppe F. https://orcid.org/0000-0002-5524-0453
Sánchez-López, Elena
van Veelen, Peter A.
Zlei, Mihaela
van Dongen, Jacques J. M.
Otte, Annemarie M.
Halkes, Constantijn J. M.
van Balen, Peter
Veelken, Hendrik
Reinders, Marcel J. T.
Griffioen, Marieke
van den Akker, Erik B. https://orcid.org/0000-0002-7693-0728
-
Funding
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VENI: 09150161810095)
This study was funded by a strategic investment of the Leiden University Medical Center, embedded within the Leiden Oncology Center, and executed within the Leiden Center for Computational Oncology.
- License Information
-
More Information
Article History
Received: 1 September 2023
Accepted: 3 May 2024
First Online: 18 May 2024
Competing interests
: J.J.M. van Dongen reports to be chairman of the EuroFlow scientific foundation, which receives royalties from licensed patents, which are collectively owned by the participants of the EuroFlow Foundation. These royalties are exclusively used for continuation of the EuroFlow collaboration and sustainability of the EuroFlow consortium. J.J.M. van Dongen also reports an Educational Services Agreement and a Scientific Advisor Agreement with BD Biosciences San José; the related fees and honoraria are for the University of Salamanca. The other authors declare no competing interests.
